EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Clinical trial NCT03594110 · COMPLETED

Trial details

NCT number: NCT03594110
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2019-01-31
Primary completion: 2022-07-05
Enrollment: 6609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.